Humalog Injection, Solution
Product Images NDC 50090-4073

Product Visual Gallery

This gallery contains 87 technical images submitted to the FDA as part of the official labeling for Humalog (NDC 50090-4073). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Humalog 5sec Clock)

An instructional icon showing a timer set to 5 seconds. The graphic features a circular clock face with a shaded segment indicating the 5-second duration, accompanied by the text '5 sec' below.*

FDA Label Image

Figure (Humalog Qr)

Humalog KwikPen 100 units/mL injection, solution in a prefilled pen. The label includes the product name, concentration, dosage form, and labeler information from A-S Medication Solutions. The packaging highlights that this insulin lispro product is for intravenous and subcutaneous use.*

FDA Label Image

Figure 1 (Humalog F001 V3)

A line graph comparing blood glucose levels (mg/dL) over time (minutes) between Humalog and Humulin R, each with 10 subjects and a mean dose of 15.4 units. The graph shows glucose response curves for both Insulin lispro (Humalog) and another insulin product, illustrating their effects over an 8-hour period.*

FDA Label Image

Figure 2 (Humalog F003 V2)

A line graph comparing serum free insulin concentration (mU/L) over time (minutes) between Humalog and Humulin R at a mean dose of 15.4 units, showing concentration changes up to 480 minutes for 10 subjects each.*

FDA Label Image

Figure (Humalog Inj Sites V1)

Illustration showing recommended injection sites on the human body for Humalog KwikPen insulin lispro 100 units/mL injection solution. Marked front sites include the abdomen and outer thighs; back sites include the upper buttocks area.*

FDA Label Image

Figure (Humalog Jr Ifu 1 V1)

Humalog Junior KwikPen insulin lispro injection, 100 units/mL, in a gray pen injector device with an orange and white label. The label shows the brand name and generic name. The pen includes a dose selector knob and a removable cap on the injection end. Labeler is A-S Medication Solutions.*

FDA Label Image

Figure (Humalog Jr Ifu 10 V2)

Close-up view of the Humalog KwikPen insulin lispro injection solution delivery device, showing the dosage dial marked at 0.5 units. The pen-style injector is gray with a textured cap, used for subcutaneous or intravenous administration of 100 units per mL insulin solution.*

FDA Label Image

Figure (Humalog Jr Ifu 11 V2)

An instructional illustration showing a close-up of a Humalog KwikPen dose window with a red arrow pointing to the dial, indicating how to set the insulin dose on the pen injector.*

FDA Label Image

Figure (Humalog Jr Ifu 12 V2)

An instructional illustration showing a close-up of a Humalog KwikPen dose selector window with a red arrow pointing to the dial, indicating dose setting functionality for insulin lispro injection solution.*

FDA Label Image

Figure (Humalog Jr Ifu 13 V2)

Illustration showing a close-up detail of a Humalog KwikPen insulin injection device, highlighting the dosage window with visible unit markings and a red arrow pointing to the number 11 on the dosage scale.*

FDA Label Image

Figure (Humalog Jr Ifu 14 V3)

An instructional illustration showing a person administering an injection into the lower abdominal area, presumably using a pen-type injector device. The image highlights the injection site and technique for subcutaneous administration.*

FDA Label Image

Figure (Humalog Jr Ifu 15 V3)

Illustration showing a close-up of the dosage window and dose selector dial on a Humalog KwikPen insulin injection device. The visible scale on the dosage window indicates unit markings for insulin dose adjustment, including 0 and 0.5 units.*

FDA Label Image

Figure (Humalog Jr Ifu 16 V3)

An instructional illustration showing a hand holding a Humalog KwikPen insulin injection pen with the cap being removed by pulling it away from the pen body, indicated by a red arrow.*

FDA Label Image

Figure (Humalog Jr Ifu 17 V3)

An instructional illustration showing a hand holding a Humalog KwikPen injection device. A red ribbon-like indicator is visible coiled around the needle tip, possibly demonstrating a step in preparing the pen for insulin lispro injection.*

FDA Label Image

Figure (Humalog Jr Ifu 18 V3)

An instructional diagram showing the removal of the cap from a Humalog KwikPen insulin injection pen. The illustration depicts the pen with its cap partially pulled off, indicated by a red arrow pointing to the left, demonstrating how to take off the cap before use.*

FDA Label Image

Figure (Humalog Jr Ifu 2 V1)

An illustrated diagram showing labeled parts of the Humalog Junior KwikPen injection device and its pen needle components. The KwikPen parts include the pen cap with clip, rubber seal, cartridge holder, plunger, label, pen body, dose indicator, dose window, and dose knob. The pen needle parts, shown separately, consist of the outer needle shield, inner needle shield, needle, and paper tab. A close-up of the dose knob is also depicted.*

FDA Label Image

Figure (Humalog Jr Ifu 3 V2)

An instructional illustration showing the removal of the needle cover from a pen injector. The image depicts a hand pulling the needle cover straight off the pen, indicated by a left-pointing red arrow.*

FDA Label Image

Figure (Humalog Jr Ifu 4 V1)

An instructional illustration showing a hand removing the protective cap from a needle by twisting it, indicated by a red curved arrow. The image is related to preparing an injection device for use.*

FDA Label Image

Figure (Humalog Jr Ifu 5 V1)

An instructional illustration showing the assembly of the Humalog KwikPen injection device tip cap being screwed onto the pen needle. A red arrow indicates the clockwise twisting motion needed to attach the cap securely.*

FDA Label Image

Figure (Humalog Jr Ifu 6 V1)

An instructional diagram showing two illustrations of needle shields for Humalog KwikPen insulin lispro injection. The first shows an outer needle shield with an arrow pointing left and text advising to keep the outer needle shield. The second shows an inner needle shield with text advising to throw it away.*

FDA Label Image

Figure (Humalog Jr Ifu 7 V2)

An instructional illustration showing a close-up of a Humalog KwikPen insulin pen with an arrow pointing to the knob, indicating an adjustment or preparation step for injecting insulin lispro solution.*

FDA Label Image

Figure (Humalog Jr Ifu 8 V2)

An instructional illustration showing a hand holding a syringe with a cap being removed or twisted off by the other hand, indicating preparation steps for injection. The syringe has measurement markings visible on the barrel.*

FDA Label Image

Figure (Humalog Jr Ifu 9 V2)

An instructional illustration showing hands holding a syringe. A close-up inset highlights the syringe tip with a droplet of liquid at the needle's end. An upward red arrow below indicates a step likely involving removing air bubbles or priming the syringe before injection.*

FDA Label Image

Primary Structure (Humalog Structure V1)

Chemical structure diagram showing amino acid sequences of the A-chain and B-chain of insulin. The diagram highlights the peptide chains with labeled amino acid residues forming disulfide bridges, illustrating the molecular structure of insulin lispro.*

FDA Label Image

Figure (Humalog Tp Ifu 1 V1)

Humalog KwikPen insulin lispro injection pen, solution for subcutaneous or intravenous use, with strength 100 units/mL. The image shows a blue and white prefilled insulin pen with a maroon cap and a dosage window. The label includes the proprietary name Humalog Tempo Pen and indicates single-patient use. Manufactured by A-S Medication Solutions.*

FDA Label Image

Figure (Humalog Tp Ifu 11 V1)

An instructional illustration showing a person holding a Humalog KwikPen insulin injection device aimed at the abdomen area. The image demonstrates the technique for subcutaneous injection by pressing the device against the skin near the waistline.*

FDA Label Image

Figure (Humalog Tp Ifu 12 V1)

The image shows a part of the Humalog KwikPen insulin injection device, featuring a blue body with a dosage window and a maroon twist-off cap. The window displays dosage settings. This device delivers insulin lispro at a strength of 100 IU/mL, labeled by A-S Medication Solutions.*

FDA Label Image

Figure (Humalog Tp Ifu 13 V2)

An instructional illustration showing a Humalog KwikPen insulin injection pen with the cap being removed, indicated by a red arrow pointing away from the pen. The pen is depicted in blue with dosage markings visible on the clear dosage window.*

FDA Label Image

Figure (Humalog Tp Ifu 2 V1)

An exploded diagram illustrating the parts of a Humalog Tempo Pen and pen needle components. The pen parts labeled include the pen cap with cap clip, rubber seal, cartridge holder, plunger, label on the pen body, dose indicator, dose window, and dose knob. The pen needle parts (needles not included) are the outer needle shield, inner needle shield, needle, and paper tab. A separate image shows the dose knob from a front view.*

FDA Label Image

Figure (Humalog Tp Ifu 3 V2)

An instructional diagram depicting the removal of the Humalog KwikPen cap by pulling it straight off in the direction indicated by a left-pointing arrow.*

FDA Label Image

Figure (Humalog Tp Ifu 4 V1)

An instructional diagram showing a close-up view of a Humalog KwikPen insulin injection device. The image highlights the dosage window with markings for units of insulin and a red arrow indicating adjustment or setting of the dose using the dosage dial.*

FDA Label Image

Figure (Humalog Tp Ifu 5 V2)

An instructional illustration showing a hand holding a Humalog KwikPen injection pen, pointing out the 'Dose Knob' at the base of the pen with an arrow indicating rotation or adjustment. A magnified inset highlights the internal mechanism or dose counter near the knob area.*

FDA Label Image

Figure (Humalog Tp Ifu 6 V1)

An illustration showing a close-up view of a dose selector on a Humalog KwikPen insulin injection device. The dial displays numbers for setting the insulin dose before injection.*

FDA Label Image

Figure (Humalog Tp Ifu 7 V1)

An instructional illustration showing a close-up of a dose selector window on a Humalog KwikPen insulin pen. A hand is gripping the pen and adjusting the dose, indicated by an arrow pointing upward within the window displaying unit measurements.*

FDA Label Image

Figure (Humalog Tp Ifu 8 V1)

Illustration showing a close-up view of the dose window on a Humalog KwikPen insulin pen. The image highlights the mechanism for setting or reading the insulin dose, indicated by a red arrow pointing to the dosage display window with visible dose markings.*

FDA Label Image

Figure (Humalog Tp Ifu 9 V1)

An instructional illustration showing a close-up of a Humalog KwikPen insulin injection device. The image focuses on the dosage dial window, highlighting a red arrow pointing to the number 26 on the dosage scale, which is marked in increments with numbers including 2, 4, 6, and 8 visible on the side.*

FDA Label Image

Figure (Humalog U100 Ifu 1 V3)

Humalog KwikPen insulin lispro injection pen device shown with blue body and a label indicating it is for single patient use only. The label includes the product name Humalog KwikPen, the generic name insulin lispro injection, and a dosing window on the adjustable dial. The pen is intended for subcutaneous and intravenous injection.*

FDA Label Image

Figure (Humalog U100 Ifu 10 V2)

The image shows a close-up of a Humalog KwikPen insulin delivery device. Visible is the blue pen cap and part of the white adjustment dial for dosing insulin lispro 100 units/mL. The labeler is A-S Medication Solutions. The device is designed for subcutaneous or intravenous injection.*

FDA Label Image

Figure (Humalog U100 Ifu 11 V2)

An instructional illustration showing a hand adjusting the dose dial on a Humalog KwikPen insulin injection device. The dose window displays graduated markings, with an arrow indicating the direction to turn the dose selector.*

FDA Label Image

Figure (Humalog U100 Ifu 12 V2)

Illustration showing a close-up of a Humalog KwikPen dose selector window with the number 12 highlighted by a red arrow, indicating dose adjustment or selection for insulin lispro injection, solution 100 IU/mL by A-S Medication Solutions.*

FDA Label Image

Figure (Humalog U100 Ifu 13 V2)

An illustration showing a close-up view of a dose selector dial on a Humalog KwikPen insulin injection pen. The dial displays numerical dose markings, with a red arrow pointing to the dose selection window, depicting the adjustment of insulin dosage.*

FDA Label Image

Figure (Humalog U100 Ifu 16 V1)

An instructional diagram showing a person administering an injection with a pen device into the abdominal area. The illustration depicts the pen being held in one hand and the injection site exposed on a person's abdomen.*

FDA Label Image

Figure (Humalog U100 Ifu 18 V1)

An instructional illustration showing a hand holding a Humalog KwikPen insulin delivery device, with the cap being removed by pulling it away from the pen. The pen is marked with dosage units, indicating its use for subcutaneous injection.*

FDA Label Image

Figure (Humalog U100 Ifu 19 V1)

An instructional illustration showing a hand holding a Humalog KwikPen insulin injection device. The image depicts a dose being dialed or adjusted, highlighting the pen’s dose measurement window and a red arrow indicating the direction of dose setting.*

FDA Label Image

Figure (Humalog U100 Ifu 2 V3)

Illustration of the component parts of a Humalog KwikPen insulin injection device and its pen needle parts. Labeled parts include the cap clip, pen clip, rubber seal, cartridge holder, plunger, label, pen body, dose indicator, dose window, and dose knob on the KwikPen. Pen needle components shown separately are the outer needle shield, inner needle shield, needle, and paper tab. A separate view of the dose knob is also provided.*

FDA Label Image

Figure (Humalog U100 Ifu 20 V3)

Instructional illustration showing the removal of the cap from a Humalog KwikPen insulin injection device. A red arrow indicates the direction to pull the cap off the pen before use.*

FDA Label Image

Figure (Humalog U100 Ifu 3 V2)

An instructional diagram showing a blue pen-shaped device being disconnected or removed by pulling it to the left, indicated by a red leftward arrow. The device appears to be part of an injection delivery system, likely a pen for insulin administration.*

FDA Label Image

Figure (Humalog U100 Ifu 4 V1)

An instructional illustration depicting a hand removing the protective cap from a vial. The image shows the cap being twisted off with an indicated upward and outward motion.*

FDA Label Image

Figure (Humalog U100 Ifu 5 V1)

Illustration showing the removal of a protective seal or cap from the tip of an injection pen. The image includes a red arrow indicating the direction to pull or peel the seal off, revealing the pen tip underneath.*

FDA Label Image

Figure (Humalog U100 Ifu 6 V1)

An instructional diagram showing how to remove the inner needle shield from an insulin pen. The first part illustrates keeping the outer needle shield on while pulling the inner needle shield off, indicated by a leftwards arrow. The second part shows discarding the removed inner needle shield, while the outer needle shield remains on the needle.*

FDA Label Image

Figure (Humalog U100 Ifu 7 V2)

An instructional illustration showing a dosage window numbered from 1 to 4 with a red arrow pointing upward, likely indicating how to adjust or dial the dose on a device such as a pen injector for medication delivery.*

FDA Label Image

Figure (Humalog U100 Ifu 8 V2)

Illustration showing a hand holding an insulin vial with the other hand adjusting the vial cap or preparing for injection. The image demonstrates proper handling technique for an injection solution, likely insulin lispro in a vial form.*

FDA Label Image

Figure (Humalog U100 Ifu 9 V2)

An instructional illustration showing a hand holding a Humalog KwikPen insulin injection device. The image highlights the step of pushing the injection button with a thumb, indicated by a red arrow, to deliver the dose. An inset magnifies the dial or window on the device, focusing on the dosage setting mechanism.*

FDA Label Image

Figure (Humalog U200 Ifu 1 V3)

Humalog KwikPen insulin lispro injection pen device. The pen is gray with a label displaying the product name, insulin lispro, and dosage strength of 100 units per mL. The label indicates it is for single patient use only and contains 200 units total. The dial shows an adjustable dose window, and the pen cap is gray with a pink inner ring.*

FDA Label Image

Figure (Humalog U200 Ifu 10 V2)

An instructional illustration showing hands holding a Humalog KwikPen insulin injection device. The image highlights the injection pen tip, possibly focusing on how to prepare or use the pen for subcutaneous or intravenous administration.*

FDA Label Image

Figure (Humalog U200 Ifu 11 V1)

Humalog KwikPen insulin lispro injection, solution 100 units per mL cartridge portion showing dose selector window with dose markings ranging from 0 to 10 units visible on the pen device designed for subcutaneous or intravenous administration by A-S Medication Solutions.*

FDA Label Image

Figure (Humalog U200 Ifu 12 V2)

An instructional illustration showing a hand holding a Humalog KwikPen insulin injection pen. The image highlights the dose selector window with an upward-pointing red arrow, indicating the step to turn the dose selector to set the desired insulin dose.*

FDA Label Image

Figure (Humalog U200 Ifu 13 V3)

An instructional diagram showing a close-up view of a dose window on a Humalog KwikPen insulin injection device. The window displays dosage markings used to set the insulin dose, with a red arrow pointing to the number 12 on the scale.*

FDA Label Image

Figure (Humalog U200 Ifu 14 V2)

An illustration showing the dosing window of a Humalog KwikPen insulin injection device. The image focuses on the dose indicator, displaying insulin units set between 24 and 26, with numeric increments on the dial. A red arrow points directly at the dose indicator for clear dose selection.*

FDA Label Image

Figure (Humalog U200 Ifu 16 V2)

An instructional illustration showing a person administering an injection using a pen device into the abdomen. The image emphasizes proper hand positioning and injection technique for subcutaneous delivery.*

FDA Label Image

Figure (Humalog U200 Ifu 19 V3)

An instructional illustration showing a hand removing the cap from a Humalog KwikPen insulin injection pen, indicating the step before administering the insulin lispro solution by subcutaneous or intravenous injection.*

FDA Label Image

Figure (Humalog U200 Ifu 2 V1)

The image shows a yellow warning label with black text reading, 'DO NOT TRANSFER TO A SYRINGE SEVERE OVERDOSE CAN RESULT.' This label is associated with Humalog KwikPen insulin lispro injection, 100 units/mL, by A-S Medication Solutions, highlighting an important safety warning about improper use.*

FDA Label Image

Figure (Humalog U200 Ifu 20 V3)

An instructional illustration showing a hand holding a Humalog KwikPen insulin injection pen labeled with dosage instructions. The image depicts the proper grip and handling technique for subcutaneous injection of insulin lispro.*

FDA Label Image

Figure (Humalog U200 Ifu 21 V3)

An instructional diagram showing the Humalog KwikPen insulin injection pen. The image includes an arrow indicating the direction of use, illustrating how to operate the pen for insulin delivery. The pen is labeled with a warning label on the cartridge area.*

FDA Label Image

Figure (Humalog U200 Ifu 3 V3)

Illustration diagram detailing the parts of a Humalog KwikPen insulin injection pen and its needle components. The pen parts labeled include the pen cap with cap clip, rubber seal, cartridge holder with safety warning label, plunger, pen body with label and dose window, dose indicator, and dose knob. The needle parts shown (needles not included) feature the outer needle shield, inner needle shield, needle, and paper tab. A separate image of the dose knob is also included.*

FDA Label Image

Figure (Humalog U200 Ifu 4 V2)

An instructional illustration showing the removal of a cap from a pen injector. The pen device is visible on the right side, with the cap on the left and an arrow pointing left indicating the direction to pull the cap off. This appears to be related to Humalog KwikPen, an insulin lispro injection.*

FDA Label Image

Figure (Humalog U200 Ifu 5 V2)

An instructional illustration showing a hand twisting the cap off a vial, with a red arrow indicating the direction for removal.*

FDA Label Image

Figure (Humalog U200 Ifu 6 V2)

An instructional diagram showing the cap removal process for a Humalog KwikPen insulin injection pen. The image depicts the pen with an arrow indicating how to twist and remove the protective cap from the needle area before use.*

FDA Label Image

Figure (Humalog U200 Ifu 7 V2)

An instructional diagram showing how to remove and discard the inner needle shield from a Humalog KwikPen insulin lispro injection pen. It advises to keep the outer needle shield and throw away the inner needle shield before use.*

FDA Label Image

Figure (Humalog U200 Ifu 8 V2)

An instructional diagram showing a close-up view of a Humalog KwikPen dose selector window with a red arrow pointing upward, indicating the motion to adjust the insulin dose on the pen injector.*

FDA Label Image

Figure (Humalog U200 Ifu 9 V2)

An instructional illustration showing a hand holding a Humalog KwikPen and another hand flicking or tapping the cartridge inside the pen, indicating a step in preparing the insulin injection.*

FDA Label Image

Figure (Humalog Vial Ifu 1 V5)

Humalog KwikPen injection vial label showing the product name Humalog KwikPen with insulin lispro solution. The label indicates 100 units per mL strength and includes a protective cap and rubber stopper under the cap. The label is primarily black and white with the Lilly logo at the bottom.*

FDA Label Image

Figure (Humalog Vial Ifu 10)

An instructional illustration showing hands drawing liquid into a syringe from a vial, with an arrow indicating upward motion. A separate close-up view of a syringe shows volume markings up to 40 units, emphasizing precise measurement during preparation.*

FDA Label Image

Figure (Humalog Vial Ifu 11)

An instructional illustration showing a hand holding a vial and another hand preparing a syringe, with an arrow indicating the step of drawing medication from the vial into the syringe, likely related to the use of Humalog KwikPen insulin lispro injection.*

FDA Label Image

Figure (Humalog Vial Ifu 12 V2)

An instructional diagram showing recommended injection sites on the human body. The front view highlights the abdomen and the front thighs, while the back view highlights the lower back near the hips. The image is related to administration of Humalog KwikPen (insulin lispro) injection, solution 100 units/mL from A-S Medication Solutions.*

FDA Label Image

Figure (Humalog Vial Ifu 13)

An instructional line drawing showing a person injecting Humalog KwikPen insulin solution subcutaneously into the abdomen. The illustration depicts one hand holding a syringe with a needle inserted into the skin while the other hand slightly pinches the abdominal area, indicating the injection technique for subcutaneous administration.*

FDA Label Image

Figure (Humalog Vial Ifu 14)

Illustration showing a person administering an injection with a syringe into the abdominal area just above the waistband, indicated by an arrow pointing to the injection site on the abdomen.*

FDA Label Image

Figure (Humalog Vial Ifu 15)

An instructional illustration showing a person administering an injection to the abdominal area, with an arrow indicating the direction for withdrawing the syringe. The image depicts proper technique for subcutaneous injection.*

FDA Label Image

Figure (Humalog Vial Ifu 2 V3)

An instructional diagram of a syringe showing labeled parts: needle shield, needle, plunger tip, syringe body, and plunger. It highlights the measurement scale on the syringe body with an example dose of 20 units indicated at the plunger tip.*

FDA Label Image

Figure (Humalog Vial Ifu 3)

An instructional diagram showing a hand holding a vial while another hand is removing the vial cap by pulling it upwards. The illustration demonstrates the step for preparing an injection vial, relevant to the Humalog KwikPen insulin lispro product.*

FDA Label Image

Figure (Humalog Vial Ifu 4)

An instructional illustration showing a hand holding a vial and peeling off or removing the cap from its top. The vial is small and cylindrical, likely representing a medication container, possibly related to the Humalog KwikPen insulin product.*

FDA Label Image

Figure (Humalog Vial Ifu 5)

An instructional diagram showing a hand holding a syringe with a needle, with an arrow indicating downward movement for injection. A close-up inset displays the syringe barrel with graduation marks for dosing.*

FDA Label Image

Figure (Humalog Vial Ifu 6)

An instructional illustration showing two hands assembling an injection pen device by attaching or removing a syringe needle. The image visually guides the user in proper handling or preparation of the injection pen for use.*

FDA Label Image

Figure (Humalog Vial Ifu 7)

An instructional line drawing showing a person holding a Humalog KwikPen insulin injection pen and inserting a syringe needle into the pen's cartridge. The image demonstrates a step in preparing the insulin pen for injection.*

FDA Label Image

Figure (Humalog Vial Ifu 8)

Instructional illustration showing a hand holding a vial being accessed with a syringe, with an arrow indicating downward direction and an inset displaying a syringe with measurement markings up to 40 units. The diagram demonstrates how to draw solution from the vial into the syringe.*

FDA Label Image

Figure (Humalog Vial Ifu 9)

An instructional illustration showing two hands preparing a syringe. One hand holds a vial upside down with the needle inserted, while the other hand holds the syringe barrel, indicating medication withdrawal or preparation for injection.*

FDA Label Image

Label Image (Lbl500904073)

Label for Humalog KwikPen U-100 injection solution containing 100 units per mL of insulin lispro. The package includes 5 prefilled pens of 3 mL each. Distributed by A-S Medication Solutions in Libertyville, Illinois. Storage instructions note refrigeration before use and no freezing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.